FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947984511> ?p ?o ?g. }

• W2947984511 abstract "Radiolabeled exendin-4 (Ex4) derivatives are used to target the glucagon-like peptide-1 receptor (GLP-1R) for the clinical diagnosis of insulinomas, a rare type of neuroendocrine tumor. Gallium-68 is an ideal diagnostic nuclide for this application and a study evaluating an exendin-4-NODAGA conjugate is currently underway. However, in complexion with the chelator DFO, its in vivo stability has been a matter of dispute. The aim of this work was to directly compare [68Ga]Ga-Ex4NOD with [68Ga]Ga-Ex4DFO in vitro and in vivo. In our approach, we directly compared N′-[5-(acetyl-hydroxy-amino)pentyl]-N-[5-[3-(5-aminopentyl-hydroxy-carbamoyl)propanoylamino]pentyl]-N-hydroxy-butane diamide (desferriox-amine B, DFO) and 2-(4,7-bis (carboxymethyl)-1,4,7-triazonan-1-yl) pentanedioic acid (NODAGA) conjugated to exendin-4 in vitro and in vivo. We radiolabeled the peptides with gallium-68, followed by HPLC quality control. In vitro characterization was performed in CHL cells overexpressing the GLP-1R and in vivo studies were conducted with CD1 nu/nu mice carrying tumors derived from these cells. We found that both peptides could be radiolabeled with a molar activity of about 9.33 MBq/nmol without further purification. They internalized equally well into GLP-1R-expressing cells and their IC50 was similar with 15.6 ± 7.8 nM and 18.4 ± 3.0 nM for [natGa]Ga-Ex4NOD and [natGa]Ga-Ex4DFO, respectively. In vivo, [68Ga]Ga-Ex4NOD accumulated more in all tissue, while [68Ga]Ga-Ex4DFO exhibited a more favorable target-to-kidney ratio. DFO is a suitable chelator for the radiolabeling of exendin-4 derivatives with gallium-68 for in vitro and preclinical in vivo studies. DFO performed better in vivo due to its significantly lower kidney accumulation (p < 0.0001). It was also found to be stable in vivo in mice, contrary to earlier reports. Based on our results, the DFO chelating system in combination with exendin-4 would be an interesting option for clinical imaging of insulinomas." @default.
• W2947984511 created "2019-06-07" @default.
• W2947984511 creator A5023477767 @default.
• W2947984511 creator A5041743198 @default.
• W2947984511 creator A5044226143 @default.
• W2947984511 creator A5066158692 @default.
• W2947984511 date "2019-05-16" @default.
• W2947984511 modified "2023-10-17" @default.
• W2947984511 title "Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4" @default.
• W2947984511 cites W1757026800 @default.
• W2947984511 cites W1966335626 @default.
• W2947984511 cites W1967331905 @default.
• W2947984511 cites W1981178839 @default.
• W2947984511 cites W1987317584 @default.
• W2947984511 cites W1990137877 @default.
• W2947984511 cites W2003639851 @default.
• W2947984511 cites W2010544188 @default.
• W2947984511 cites W2038304520 @default.
• W2947984511 cites W2054812129 @default.
• W2947984511 cites W2064276702 @default.
• W2947984511 cites W2067267904 @default.
• W2947984511 cites W2080916065 @default.
• W2947984511 cites W2084948079 @default.
• W2947984511 cites W2102012957 @default.
• W2947984511 cites W2116916132 @default.
• W2947984511 cites W2135112988 @default.
• W2947984511 cites W2148239074 @default.
• W2947984511 cites W2153881254 @default.
• W2947984511 cites W2157585503 @default.
• W2947984511 cites W2262303485 @default.
• W2947984511 cites W2270779389 @default.
• W2947984511 cites W2329026997 @default.
• W2947984511 cites W2336311265 @default.
• W2947984511 cites W2516932474 @default.
• W2947984511 cites W2563795001 @default.
• W2947984511 cites W2566643566 @default.
• W2947984511 cites W2575654663 @default.
• W2947984511 cites W2618233912 @default.
• W2947984511 cites W2765367326 @default.
• W2947984511 cites W2775482265 @default.
• W2947984511 cites W2790574529 @default.
• W2947984511 cites W2799412190 @default.
• W2947984511 doi "https://doi.org/10.1186/s41181-019-0060-9" @default.
• W2947984511 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6522624" @default.
• W2947984511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31659487" @default.
• W2947984511 hasPublicationYear "2019" @default.
• W2947984511 type Work @default.
• W2947984511 sameAs 2947984511 @default.
• W2947984511 citedByCount "9" @default.
• W2947984511 countsByYear W29479845112020 @default.
• W2947984511 countsByYear W29479845112021 @default.
• W2947984511 countsByYear W29479845112022 @default.
• W2947984511 countsByYear W29479845112023 @default.
• W2947984511 crossrefType "journal-article" @default.
• W2947984511 hasAuthorship W2947984511A5023477767 @default.
• W2947984511 hasAuthorship W2947984511A5041743198 @default.
• W2947984511 hasAuthorship W2947984511A5044226143 @default.
• W2947984511 hasAuthorship W2947984511A5066158692 @default.
• W2947984511 hasBestOaLocation W29479845111 @default.
• W2947984511 hasConcept C134306372 @default.
• W2947984511 hasConcept C150903083 @default.
• W2947984511 hasConcept C178790620 @default.
• W2947984511 hasConcept C185592680 @default.
• W2947984511 hasConcept C197336794 @default.
• W2947984511 hasConcept C197404232 @default.
• W2947984511 hasConcept C202751555 @default.
• W2947984511 hasConcept C207001950 @default.
• W2947984511 hasConcept C2776970183 @default.
• W2947984511 hasConcept C2779281246 @default.
• W2947984511 hasConcept C33923547 @default.
• W2947984511 hasConcept C550372918 @default.
• W2947984511 hasConcept C55493867 @default.
• W2947984511 hasConcept C71240020 @default.
• W2947984511 hasConcept C86803240 @default.
• W2947984511 hasConcept C98274493 @default.
• W2947984511 hasConceptScore W2947984511C134306372 @default.
• W2947984511 hasConceptScore W2947984511C150903083 @default.
• W2947984511 hasConceptScore W2947984511C178790620 @default.
• W2947984511 hasConceptScore W2947984511C185592680 @default.
• W2947984511 hasConceptScore W2947984511C197336794 @default.
• W2947984511 hasConceptScore W2947984511C197404232 @default.
• W2947984511 hasConceptScore W2947984511C202751555 @default.
• W2947984511 hasConceptScore W2947984511C207001950 @default.
• W2947984511 hasConceptScore W2947984511C2776970183 @default.
• W2947984511 hasConceptScore W2947984511C2779281246 @default.
• W2947984511 hasConceptScore W2947984511C33923547 @default.
• W2947984511 hasConceptScore W2947984511C550372918 @default.
• W2947984511 hasConceptScore W2947984511C55493867 @default.
• W2947984511 hasConceptScore W2947984511C71240020 @default.
• W2947984511 hasConceptScore W2947984511C86803240 @default.
• W2947984511 hasConceptScore W2947984511C98274493 @default.
• W2947984511 hasFunder F4320334960 @default.
• W2947984511 hasIssue "1" @default.
• W2947984511 hasLocation W29479845111 @default.
• W2947984511 hasLocation W29479845112 @default.
• W2947984511 hasLocation W29479845113 @default.
• W2947984511 hasLocation W29479845114 @default.
• W2947984511 hasLocation W29479845115 @default.
• W2947984511 hasLocation W29479845116 @default.
• W2947984511 hasOpenAccess W2947984511 @default.

• next